ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 286193 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 286193; 2) Community: the network communities that were significantly associated with the response to NSC 286193; 3) Molecule: the relationships between components within communities and NSC 286193; 4) MDR: the compounds that were significantly associated with the NSC 286193.

NSC Compound Enrichment Correlation
NSC 743380 1H-Indole-3-methanol, 1-[(3-chlorophenyl)methyl]- 0.00109467026514912 -0.14788752
NSC 623527 Pyrrolidinium, N-(5-carboxypentyl)-N- [2-[2-[3-(octadecyloxy)-2-[(pyrimidine-2yl)oxy]propyloxy] ethoxy]ethyl]-, inner salt 0.00119931827492062 0.31792958
NSC 684836 Butanamide, N-[2-[(4-fluorophenyl)amino]-1,1,1,3,3,3- hexafluoro-2-propyl]- 0.00119931827492062 0.25246772
NSC 763646 (E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole 0.00119931827492062 0.33435329
NSC 5639 Null 0.00120351220784448 0.29576732
NSC 694610 2,3-Dihydro-2,3-dihydroxy-brefeldin A 0.00138752552318951 0.015734309
NSC 749028 Null 0.00138752552318951 0.25378015
NSC 758535 Null 0.00138752552318951 0.37874761
NSC 104801 Cytembena 0.0018088833864761 0.010653412
NSC 608984 Leucinostatine D 0.00180888338647612 0.079866474
Total:96  Current:4    [First] [Prev] [Next] [Last]